Axogen (AXGN) Cash from Financing Activities (2010 - 2026)

Axogen (AXGN) recorded quarterly Cash from Financing Activities of $59.5 million in Q1 2026, up 1203.22% quarter-over-quarter from $4.6 million in Q4 2025, and up 2398.11% on a YoY basis from $2.4 million in Q1 2025.

Axogen (AXGN) Cash from Financing Activities (2010 - 2026) Analysis & Trends

Axogen's Cash from Financing Activities history runs 17 years deep, the most recent figure standing at $59.5 million for Q1 2026.

  • In Q1 2026, Cash from Financing Activities rose 2398.11% year-over-year to $59.5 million; the TTM figure through Mar 2026 stood at $67.6 million (up 1413.47% YoY), while the FY2025 annual figure was $10.5 million, up 358.47% from the prior year.
  • Cash from Financing Activities was $59.5 million for Q1 2026 at Axogen, up from $4.6 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $59.5 million in Q1 2026 to a low of $5000.0 in Q3 2023.
  • Historically, Cash from Financing Activities has averaged $4.5 million across 5 years, with a median of $671000.0 in 2022.
  • The sharpest annual moves came in 2023 and 2024: Cash from Financing Activities slumped 97.67% in 2023, then surged 11340.0% in 2024.
  • A 5-year view of Cash from Financing Activities shows it stood at $813000.0 in 2022, then sank by 48.59% to $418000.0 in 2023, then soared by 132.06% to $970000.0 in 2024, then jumped by 370.72% to $4.6 million in 2025, then soared by 1203.22% to $59.5 million in 2026.
  • The last three Cash from Financing Activities figures came in at $59.5 million (Q1 2026), $4.6 million (Q4 2025), and $2.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 17.31 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -1.51 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -2.09 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -260.00 Mn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -451.20 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -26.93 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -25.00 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 21.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -97.90 Mn
10 Axogen 2.32 Bn 2.22 Bn 46.19 Mn 59.51 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 59.51 Mn
Mar 31, 2026 59.51 Mn
Dec 31, 2025 4.57 Mn
Dec 31, 2025 4.57 Mn
Sep 30, 2025 2.39 Mn
Sep 30, 2025 2.39 Mn
Jun 30, 2025 1.16 Mn
Jun 30, 2025 1.16 Mn
Mar 31, 2025 2.38 Mn
Mar 31, 2025 2.38 Mn
Dec 31, 2024 970,000.00
Dec 31, 2024 970,000.00
Sep 30, 2024 572,000.00
Sep 30, 2024 572,000.00
Jun 30, 2024 544,000.00
Jun 30, 2024 544,000.00
Mar 31, 2024 204,000.00
Mar 31, 2024 204,000.00
Dec 31, 2023 418,000.00
Dec 31, 2023 418,000.00